Propofol versus Dexmedetomidine for Sedation of Cancer Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: Randomized Single-Blinded Controlled Study.

The article discusses research which compared the efficacy of dexmedetomidine and propofol in sedating cancer patients during endoscopic retrograde cholangiopancreatography (ERCP). Topics explored include the diagnostic and therapeutic applications for ERCP, the dexmedetomidine and propofol dosage administered to patients involved in the study, and the vital signs and patient outcomes recorded following the procedure.